Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

Background:Combination of age at diagnosis, stage and MYCN amplification stratifies neuroblastoma into low-risk and high-risk. We aimed to establish whether a microRNA (miRNA) signature could be associated with prognosis in both groups.Methods:Microarray expression profiling of human miRNAs and quantitative reverse-transcriptase PCR of selected miRNAs were performed on a preliminary cohort of 13 patients. Results were validated on an independent cohort of 214 patients. The relationship between miRNA expression and the overall or disease-free survival was analysed on the total cohort of 227 patients using the log-rank test and the multivariable Cox proportional hazard model.Results:A total of 15 of 17 miRNAs that discriminated high-risk from low-risk neuroblastoma belonged to the imprinted human 14q32.31 miRNA cluster and two, miR-487b and miR-410, were significantly downregulated in the high-risk group. Multivariable analyses showed miR-487b expression as associated with overall survival and disease-free survival in the whole cohort, independently of clinical covariates. Moreover, miR-487b and miR-410 expression was significantly associated with disease-free survival of the non-MYCN-amplified favourable neuroblastoma: localised (stage 1, 2 and 3) and stage 4 of infant <18 months.Conclusion:Expression of miR-487b and miR-410 shows predictive value beyond the classical high-/low-risk stratification and is a biomarker of relapse in favourable neuroblastoma.

• Publication year

  2011

• Venue

  British Journal of Cancer

• Publication date

  2011-10-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.2011.388PMID 21970883PMCID 3241557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma

  2011cited by this paper
• Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.

  2011cited by this paper
• Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.

  2010cited by this paper
• Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

  2010cited by this paper
• Therapeutic targeting of miRNAs in neuroblastoma

  2010cited by this paper
• Localization‐ and mutation‐dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co‐expressed miRNAs located at 14q32.31

  2010cited by this paper
• Gliomas display a microRNA expression profile reminiscent of neural precursor cells.

  2010cited by this paper
• Recent advances in neuroblastoma.

  2010influential reference
• MicroRNA as modulators of neuronal responses

  2009cited by this paper
• The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

  2009cited by this paper
• The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

  2009cited by this paper
• Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival

  2009cited by this paper
• Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification.

  2009cited by this paper
• Overall genomic pattern is a predictor of outcome in neuroblastoma.

  2009cited by this paper
• Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region

  2008cited by this paper
• Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

  2008cited by this paper
• Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.

  2008cited by this paper
• MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

  2008cited by this paper
• Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals.

  2008cited by this paper
• Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

  2007cited by this paper
• MicroRNA genes are frequently located near mouse cancer susceptibility loci

  2007cited by this paper
• MYCN regulates oncogenic MicroRNAs in neuroblastoma

  2007cited by this paper
• miRBase: tools for microRNA genomics

  2007influential reference
• Molecular biology of neuroblastoma

  2007cited by this paper
• High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12.

  2006cited by this paper
• Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.

  2005cited by this paper
• Use of within-array replicate spots for assessing differential expression in microarray experiments

  2005influential reference
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain.

  2004cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003influential reference
• Quality assessment of genetic markers used for therapy stratification.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Loss of heterozygosity for chromosome 14q in neuroblastoma.

  2001cited by this paper
• Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker

  2000cited by this paper
• Molecular biology of neuroblastoma.

  1999cited by this paper
• Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

  1999cited by this paper
• Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

  1999cited by this paper
• Stability of phenotypic and genotypic traits during the establishment of a human neuroblastoma cell line, IGR‐N‐835

  1989cited by this paper
• Molecular and Cellular Pathobiology Microrna Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma

  year unknowncited by this paper

• Transcriptome-based screening in TARDBP/TDP-43 knock-in motor neurons identifies the NEDD8-activating enzyme inhibitor MLN4924

  2024cites this paper
• Development and validation of a 21-gene prognostic signature in neuroblastoma

  2023cites this paper
• The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms

  2023cites this paper
• Chromosome 1p status in neuroblastoma correlates with higher expression levels of miRNAs targeting neuronal differentiation pathway

  2023cites this paper
• Targeting the epigenome of cancer stem cells in pediatric nervous system tumors

  2023cites this paper
• EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma

  2023cites this paper
• The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets

  2022cites this paper
• The clinical utility of dysregulated microRNA expression in paediatric solid tumours.

  2022cites this paper
• MicroRNAs as prospective biomarkers, therapeutic targets and pharmaceuticals in neuroblastoma

  2022cites this paper
• A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy

  2022cites this paper
• Clinical implications of noncoding RNAs in neuroblastoma patients

  2022cites this paper
• microRNA Profile Associated with Positive Lymph Node Metastasis in Early-Stage Cervical Cancer

  2022cites this paper
• Neuroblastoma and the epigenome

  2021cites this paper
• Clinical significance of serum miR-487b in HBV-related hepatocellular carcinoma and its potential mechanism

  2021cites this paper
• In silico model for miRNA-mediated regulatory network in cancer

  2021cites this paper
• MiRNAs in early brain development and pediatric cancer

  2021cites this paper
• Systemic biological study for identification of miR-299-5p target genes in cancer

  2020cites this paper
• miR-487b and TRAK2 that form an axis to regulate the aggressiveness of osteosarcoma, are potential therapeutic targets and prognostic biomarkers.

  2020cites this paper
• CircPRMT5 circular RNA promotes proliferation of colorectal cancer through sponging miR‐377 to induce E2F3 expression

  2020cites this paper
• Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities

  2020cites this paper
• One-pot synthesized gold nanoparticle-peptide nanotube modified disposable sensor for impedimetric recognition of miRNA 410

  2020cites this paper
• Autophagy-mediating microRNAs in cancer chemoresistance

  2020cites this paper
• Current Challenges in the Management of Neuroblastoma

  2019cites this paper
• Post-transcriptional regulation of miRNA biogenesis

  2019cites this paper
• DNA methylation‐regulated and tumor‐suppressive roles of miR‐487b in colorectal cancer via targeting MYC, SUZ12, and KRAS

  2019cites this paper
• The Role of miRNAs from the 14q32 Region in Acquired Resistance to Lapatinib

  2019cites this paper
• Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas

  2018cites this paper
• Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease

  2018cites this paper
• MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells

  2018cites this paper
• miR-487b mitigates allergic rhinitis through inhibition of the IL-33/ST2 signaling pathway.

  2018cites this paper
• Effects of Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi on apoptosis, DNA damage response, drug sensitivity, and HSA-MIR-495-3P overexpression in breast cancer

  2018cites this paper
• MicroRNA profiles in neuroblastoma: Differences in risk and histology groups

  2018cites this paper
• MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN

  2018cites this paper
• miR-377 targets CUL4A and regulates metastatic capability in ovarian cancer

  2018cites this paper
• Regulation of UGT 2 B 4 and UGT 2 B 7 by miRNAs in liver cancer cells

  2017cites this paper
• miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway.

  2017cites this paper
• Identification of microRNA-487b as a negative regulator of liver metastasis by regulation of KRAS in colorectal cancer.

  2017cites this paper
• A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer

  2017cites this paper
• Genome-wide identification of novel ovarian-predominant miRNAs: new insights from the medaka (Oryzias latipes)

  2017cites this paper
• miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.

  2017cites this paper
• Importance of miR-299-5p in colorectal cancer

  2017cites this paper
• Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9

  2017cites this paper
• MicroRNA-143 shows tumor suppressive effects through inhibition of oncogenic K-Ras in pituitary tumor.

  2017cites this paper
• miR-487b mitigates chronic heart failure through inhibition of the IL-33/ST2 signaling pathway

  2017cites this paper
• Regulation of UDP-Glucuronosyltransferases UGT2B4 and UGT2B7 by MicroRNAs in Liver Cancer Cells

  2017cites this paper
• Regulation of UGT2B4 and UGT2B7 by miRNAs in liver cancer cells

  2017cites this paper
• Potential applications of MEG3 in cancer diagnosis and prognosis

  2017cites this paper
• MiRNA expression changes in arsenic-induced skin cancer in vitro and in vivo.

  2017cites this paper
• Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer.

  2017cites this paper
• Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients

  2016cites this paper
• miR-410 controls adult SVZ neurogenesis by targeting neurogenic genes.

  2016cites this paper
• WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non‐MYCN‐amplified neuroblastoma

  2016cites this paper
• Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.

  2016cites this paper
• MicroRNA profiling of low grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b

  2016cites this paper
• miR-410-3p suppresses breast cancer progression by targeting Snail.

  2016cites this paper
• Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas

  2016cites this paper
• Reduced expression of miR-411 in intestinal type of gastric adenocarcinoma

  2016cites this paper
• A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma

  2016cites this paper
• MicroRNA-410 alleviates retinopathy of prematurity in a mouse model by inhibiting vascular endothelial growth factor expression

  2016cites this paper
• MicroRNA and pediatric tumors: Future perspectives.

  2015cites this paper
• Differential distribution of U6 (RNU6-1) expression in human carcinoma tissues demonstrates the requirement for caution in the internal control gene selection for microRNA quantification.

  2015cites this paper
• MiR-1188 at the imprinted Dlk1-Dio3 domain acts as a tumor suppressor in hepatoma cells

  2015cites this paper
• MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma

  2015cites this paper
• miR-487b, miR-3963 and miR-6412 delay myogenic differentiation in mouse myoblast-derived C2C12 cells

  2015cites this paper
• VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma

  2015cites this paper
• Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.

  2015cites this paper
• miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

  2015cites this paper
• The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop

  2015cites this paper
• iR-487 b promotes human umbilical vein endothelial cell roliferation , migration , invasion and tube formation through egulating THBS 1

  2015cites this paper
• Genome‐wide small noncoding RNA profiling of pediatric high‐grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII‐52 and delineates H3F3A and TP53 mutant‐specific miRNAs and snoRNAs

  2015cites this paper
• MicroRNA‐410 promotes cell proliferation by targeting BRD7 in non‐small cell lung cancer

  2015cites this paper
• Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.

  2015cites this paper
• MicroRNA‐410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer

  2015cites this paper
• A Computational Framework for Design and Development of Novel Prostate Cancer Therapies

  2015cites this paper
• Régulation épigénétique de la lipolyse intravasculaire des triglycérides

  2015cites this paper
• Modulated expression of human peripheral blood microRNAs from infancy to adulthood and its role in aging

  2014cites this paper
• MiR-410 Is Overexpressed in Liver and Colorectal Tumors and Enhances Tumor Cell Growth by Silencing FHL1 via a Direct/Indirect Mechanism

  2014cites this paper
• Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor

  2014cites this paper
• Significance and Therapeutic Value of miRNAs in Embryonal Neural Tumors

  2014cites this paper
• The roles of microRNAs in neuroblastoma

  2014cites this paper
• MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer

  2014cites this paper
• Role of a Novel microRNA in Adult Neurogenesis.

  2014cites this paper
• Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma.

  2014cites this paper
• MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells

  2014cites this paper
• MicroRNA expression profiles of peripheral blood mononuclear cells in patients with systemic lupus erythematosus.

  2014cites this paper
• Role and Regulation of SnoN/SkiL and PLSCR1 Located at 3q26.2 and 3q23, Respectively, in Ovarian Cancer Pathophysiology

  2014cites this paper
• Molecular mechanisms and tumour heterogeneity in breast cancer

  2014cites this paper
• MicroRNAs in Neuroblastoma: Small-Sized Players with a Large Impact

  2014cites this paper
• Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients

  2014cites this paper
• MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma

  2013cites this paper
• [Explicative models of cancer biology: an enlarged vision].

  2013cites this paper
• Pregnancy-associated miRNA-clusters.

  2013cites this paper
• Serum miR-29a as a marker of multiple myeloma

  2013cites this paper
• miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer

  2013cites this paper
• Extension of microRNA expression pattern associated with high-risk neuroblastoma

  2013cites this paper
• Potentially Prognostic miRNAs in HPV-Associated Oropharyngeal Carcinoma

  2013cites this paper
• MiR-106a is an independent prognostic marker in patients with glioblastoma.

  2013cites this paper
• Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.

  2013cites this paper
• Differentially Expressed Wound Healing-Related microRNAs in the Human Diabetic Cornea

  2013cites this paper
• The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis

  2012cites this paper